U.S. flag

An official website of the United States government

NM_001038603.3(MARVELD2):c.900G>A (p.Leu300=) AND not specified

Germline classification:
Likely benign (2 submissions)
Last evaluated:
Oct 9, 2017
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000151015.6

Allele description [Variation Report for NM_001038603.3(MARVELD2):c.900G>A (p.Leu300=)]

NM_001038603.3(MARVELD2):c.900G>A (p.Leu300=)

Gene:
MARVELD2:MARVEL domain containing 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q13.2
Genomic location:
Preferred name:
NM_001038603.3(MARVELD2):c.900G>A (p.Leu300=)
HGVS:
  • NC_000005.10:g.69420285G>A
  • NG_017201.2:g.10174G>A
  • NM_001038603.3:c.900G>AMANE SELECT
  • NM_001244734.2:c.900G>A
  • NP_001033692.2:p.Leu300=
  • NP_001231663.1:p.Leu300=
  • LRG_1380t1:c.900G>A
  • LRG_1380:g.10174G>A
  • LRG_1380p1:p.Leu300=
  • NC_000005.9:g.68716112G>A
  • NG_017201.1:g.10174G>A
  • NM_001038603.2:c.900G>A
  • p.Leu300Leu
Links:
dbSNP: rs138680809
NCBI 1000 Genomes Browser:
rs138680809
Molecular consequence:
  • NM_001038603.3:c.900G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001244734.2:c.900G>A - synonymous variant - [Sequence Ontology: SO:0001819]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000198733Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Likely benign
(Apr 30, 2012)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV000723702GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely benign
(Oct 9, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000198733.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

Leu300Leu in Exon 02 of MARVELD2: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 0.4% (14/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs138680809).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

From GeneDx, SCV000723702.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024